Verisante Technology Inc. V.VRS

RE: RE: RE: RE: RE: RE: Sales estimates

[andyran]

One more enjoyable tidbit:

 

Mr. Braun estimates that there are about 500 dermatologists in Canada, 21,000 in Europe and 350 in Australia, where an additional 1,000 general practitioners are specially trained to treat skin cancer. In addition, there are about 9,500 dermatologists in the U.S. “We’re targeting 14% penetration of dermatologists by year five after launch.”

This last paragraph makes my eyes light up. 22,000 derms x 14% market penetration is over 3,000 units in the first 5 years. At $60k/Aura that's $185M in device sales, $22m in tip sales(assuming 60 tips per month x 3,080 devices x 12 x $10/tip), $92m in service contract revenue. Almost $300m in revenues in the first 5 years with 14% market penetration in just the already approved sales markets. This doesn't include the potential of FDA approval which is obviously massive or the introduction of The Core which could be a very important device to detect lung cancer; nor does it include deeper market penetration.